Eczema Clinical Trial

This study is an investigational drug called nemolizumab as a possible treatment for atopic dermatitis. An investigational drug (also known as the “study drug”) is one that has not been approved by the United States (US) Food and Drug Administration (FDA).

This study involves clinical research. Clinical research studies help doctors and researchers understand how a study drug works before it is made available to other patients. The study drug is only given during clinical research studies and is not available to other patients.

You are being asked to take part in this study because you have had chronic atopic dermatitis for at least 2 years. In this form, atopic dermatitis is called “AD” for short. Doctors and researchers want to know if nemolizumab can help people with AD.